Table 3.
Group | GRSI | ΔGRSI | Confirmed | ΔConfirmed | Death | ΔDeath |
ALL | ||||||
CADF | -2.311 | -6.203⁎⁎* | -2.289 | -6.404⁎⁎* | -2.178 | -6.420⁎⁎* |
CIPS | -2.295 | -5.980⁎⁎* | -2.381 | -6.175⁎⁎* | -2.474 | -6.190⁎⁎* |
ASIA | ||||||
CADF | -2.504 | -6.412⁎⁎* | -2.153 | -6.420⁎⁎* | -2.288 | -6.409⁎⁎* |
CIPS | -2.326 | -6.190⁎⁎* | -2.077 | -6.190⁎⁎* | -2.519 | -6.185⁎⁎* |
NON-ASIA | ||||||
CADF | -1.970 | -6.234⁎⁎* | -2.225 | -6.396⁎⁎* | -2.047 | -6.420⁎⁎* |
CIPS | -1.967 | -6.019⁎⁎* | -2.442 | -6.168⁎⁎* | -2.363 | -6.190⁎⁎* |
Notes: The statistic of CADF is t-bar, the critical value of t-bar for the CADF test for the ALL sample at the 1%, 5%, and 10% levels is -2.620, -2.550, and -2.500, respectively; while that for the ASIA sub-sample is -2.770, -2.650, and -2.590, respectively; and that for the NON-ASIA sub-sample is -2.650, -2.570, and -2.520, respectively; The critical value for the CIPS test for the ALL sample at the 1%, 5%, and 10% levels is -2.62, -2.55, and -2.51, respectively; while that for the ASIA sub-sample is -2.77, -2.65, and -2.59, respectively; and that for the NON-ASIA sub-sample is -2.65, -2.57, and -2.52, respectively. ⁎⁎⁎
, and * denote statistical significance at the 1%, 5%, and 10% levels, respectively.